Limpet 3 MG


Limpet 3 MG


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)






Glimepiride is shown in taking after conditions-

  • Glimepiride is shown as an aide to slim down and work out to lower the blood glucose in patients with noninsulin subordinate (Sort II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by count calories and work out alone.
  • Glimepiride may be utilized concomitantly with metformin when count calorieswork out, and Glimepiride or metformin alone does not result in satisfactory glycaemic control.
  • Glimepiride is additionally demonstrated for utilize in combination with affront to lower blood glucose in patients whose hyperglycaemia cannot be controlled by eat less and work out in conjunction with an verbal hypoglycaemic agent.
  • Combined utilize of Glimepiride and affront may increment the potential for hypoglycaemia.



Glimepiride may be a sulfonylurea antidiabetic specialist which diminishes blood glucose concentration. The essential instrument of activity of Glimepiride shows up to be subordinate on fortifying the discharge of affront from working pancreatic beta cells. Glimepiride acts in concert with glucose by progressing the affectability of beta cells to physiological glucose boost, coming about in affront discharge. In expansion, extrapancreatic impacts like lessening of basal hepatic glucose generation, expanded fringe tissue affectability to affront and glucose take-up may moreover play part within the movement of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic activity of a single dosage of Glimepiride holds on for 24 hours.



In guideline, the dose of Glimepiride is represented by the required blood sugar level. The dose of Glimepiride must be the lowest which is adequate to realize the required metabolic control. The beginning and the support measurements are set based on the comes about of standard check of glucose in blood and pee. Checking of glucose levels in blood and pee too serves to identify either essential or auxiliary disappointment of therapy.

Introductory dosage and measurements titration: the normal introductory measurements is 1 mg once day by day, on the off chance that vital, the day by day measurements can be expanded. Any increment can be based on standard blood sugar checking, and ought to be progressive, i.e., at interims of 1 to 2 weeks, and carried out stepwise, as takes after: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.

Dosage in patients with well controlled diabetes: the normal measurements run in patients with well controlled diabetes is 1 to 4 mg daily. Distribution of measurements: Timing and dispersion of measurements are chosen by the doctor, in thought of the patient’s current life-style. Regularly, a single every day measurements is adequate. This ought to be taken instantly some time recently a significant breakfast or in case none is taken quickly some time recently the primary fundamental dinner. It is exceptionally vital not to skip suppers after taking the medicate.

Auxiliary dose alteration: As control of diabetes makes strides, affectability to insuiin increments; hence, Glimepiride prerequisite may drop as treatment continues. To maintain a strategic distance from hypoglycaemia, convenient dosage lessening or cessation of Glimepiride treatment must be considered. A dosage alteration must too be considered at whatever point the patient’s weight or life-styie changes, or other components emerge which cause an expanded vulnerability to hypo or hyperglycaemia.



Glimepiride tablet must be gulped with adequate sum of fluid.



Based on encounter with Glimepiride and known intelligent for other sulfonylureas, the taking after intuitive must be considered.

In expansion to affront and other verbal antidiabetic specialists, drugs which may potentiate the hypoglycaemic activity of Glimepiride incorporate: Expert inhibitors, aminosalicylic corrosive, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin subsidiaries, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (tall dosage parenteral), oxyphenbutazone, para-aminosalicylic corrosive, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide anti-microbials, tetracyclines, tritoqualine, trofosfamide.
Drugs which may constrict the hypoglycaemic activity of Glimepiride include: 

  • Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, purgatives, nicotinic corrosive (tall measurements), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic operators, thyroid hormones.
  • H2 receptor opponents, beta-blockers, clonidine and reserpine may lead to either potentiation or debilitating of the blood-glucose-lowering effect.
  • Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may veil the caution indications of a hypoglycaemic attack.
  • Acute and unremitting aicohol admissions may either potentiate or constrict the action of Glimepiride in an unusual design.



Glimepiride isn’t reasonable for the treatment of affront subordinate (sort I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be utilized in patients extremely touchy to Glimepiride, other sulfonylureas, other sulfonamides, serious hepatic brokenness, extreme disability of renal work and dialysis patients.Glimepiride isn’t reasonable for the treatment of affront subordinate (sort I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be utilized in patients extremely touchy to Glimepiride, other sulfonylureas, other sulfonamides, serious hepatic brokenness, extreme disability of renal work and dialysis patients.


Side Effects

Hypoglycaemia, transitory visual disabilityqueasinessspewingthe runsstomach torment, urticaria, drop in blood weight.


Pregnancy & Lactation

Glimepiride must not be taken amid pregnancy; a changeover to affront is essential. Patients arranging a pregnancy must advise their doctor, and ought to alter over to affront. Ingestion of Glimepiride with breast drain nourishing may hurt the child. Subsequently, Glimepiride must not be taken by breastfeeding ladies. Either a changeover or total suspension of breastfeeding is essential.


Precautions & Warnings

Within the beginning weeks of treatment, the chance of hypoglycaemia may be expanded and requires cautious checking. In case such hazard display it may be fundamental to alter the measurement of Glimepiride, Hypoglycaemia can nearly be expeditiously controlled by prompt admissions of carbohydrates (glucose or sugar).


Therapeutic Class



Storage Conditions

Do not store above 30°C. Keep away from light and out of the reach of children.


Pharmaceutical Name

Drug International Ltd.